Humans

Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients.

Pergam SA, Xie H, Sandhu R, Pollack M, Smith J, Stevens-Ayers T, et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation// Biol Blood Marrow Transplant. 2012;18(9):1391-400.

Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor.

Glowacka I, Korn K, Potthoff SA, Lehmann U, Kreipe HH, Ivens K, et al. Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America// Clin Infect Dis. 2013;57(10):1417-24.

De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants.

Balamuthia mandrillaris meningoencephalitis associated with solid organ transplantation--review of cases.

Transmission of Balamuthia mandrillaris through solid organ transplantation: utility of organ recipient serology to guide clinical management.

Gupte AA, Hocevar SN, Lea AS, Kulkarni RD, Schain DC, Casey MJ, et al. Transmission of Balamuthia mandrillaris through solid organ transplantation: utility of organ recipient serology to guide clinical management. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons// Am J Transplant. 2014;14(6):1417-24.

Pages